Page last updated: 2024-10-31

metyrapone and Glaucoma, Suspect

metyrapone has been researched along with Glaucoma, Suspect in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwartz, B1
Wysocki, A1
Qi, Y1

Other Studies

1 other study available for metyrapone and Glaucoma, Suspect

ArticleYear
Decreased response of plasma cortisol to intravenous metyrapone in ocular hypertension and primary open-angle glaucoma.
    Journal of glaucoma, 2005, Volume: 14, Issue:6

    Topics: Aged; Enzyme Inhibitors; Female; Glaucoma, Open-Angle; Humans; Hydrocortisone; Hypothalamo-Hypophyse

2005